Balance Sheet StrengthLow leverage and a strong equity ratio provide durable financial resilience: they reduce refinancing risk, support investment in R&D or capacity, and allow the firm to withstand demand cycles without relying heavily on external debt. This underpins long-term strategic optionality.

Diversified Product & Channel MixA multi-segment business model (branded formulations, consumer healthcare, medical devices and institutional sales) reduces single-market exposure, enables cross-selling, and smooths revenue volatility from tender cycles or retail demand shifts, supporting steadier medium-term cashflows.

Revenue Growth & Gross MarginsSustained revenue expansion paired with robust gross margins indicates effective pricing and cost control at the product level. This combination creates lasting operating leverage potential and capacity to reinvest in brands, salesforce, and product development over the next several quarters.

Bears Say

Negative Operating Cash FlowPersistent negative operating and free cash flow constrain the company’s ability to self-fund capex, working capital needs, dividends, or acquisitions. Over months this can force dependence on external financing, increasing cost of capital and limiting strategic flexibility.

Declining EBITDA MarginA falling EBITDA margin signals rising operating costs or loss of scale economics. If structural, it will erode operating cash conversion and return on invested capital, making it harder to sustain investment in growth initiatives and protect profitability over the medium term.

Earnings DeteriorationMaterial negative EPS growth despite revenue gains suggests pressure on net profitability from higher costs, non-operating items, or tax/finance charges. Continued EPS decline undermines retained earnings accumulation and can signal weakening earnings quality over several quarters.

TTK Healthcare Limited News

TTK Healthcare Seeks Shareholder Nod via E-Voting to Appoint New Independent Director

TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) has issued an announcement. TTK Healthcare Limited has launched a postal ballot...

2M ago

TTK Healthcare Board Appoints New Independent Director, Seeks Shareholder Nod via Postal Ballot

An update from TTK Healthcare Limited ( ($IN:TTKHLTCARE) ) is now available. TTK Healthcare Limited’s board has approved...

2M ago

TTKHLTCARE FAQ

What was TTK Healthcare Limited’s price range in the past 12 months?

TTK Healthcare Limited lowest stock price was ₹906.30 and its highest was ₹1402.00 in the past 12 months.

What is TTK Healthcare Limited’s market cap?

TTK Healthcare Limited’s market cap is ₹12.91B.

When is TTK Healthcare Limited’s upcoming earnings report date?

TTK Healthcare Limited’s upcoming earnings report date is May 22, 2026 which is in 83 days.

How were TTK Healthcare Limited’s earnings last quarter?

TTK Healthcare Limited released its earnings results on Jan 22, 2026. The company reported ₹7.454 earnings per share for the quarter, beating the consensus estimate of N/A by ₹7.454.

Is TTK Healthcare Limited overvalued?

According to Wall Street analysts TTK Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does TTK Healthcare Limited pay dividends?

TTK Healthcare Limited pays a Annually dividend of ₹10 which represents an annual dividend yield of 0.95%. See more information on TTK Healthcare Limited dividends here

What is TTK Healthcare Limited’s EPS estimate?

TTK Healthcare Limited’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does TTK Healthcare Limited have?

TTK Healthcare Limited has 14,130,333 shares outstanding.

What happened to TTK Healthcare Limited’s price movement after its last earnings report?

TTK Healthcare Limited reported an EPS of ₹7.454 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.839%.

Which hedge fund is a major shareholder of TTK Healthcare Limited?

Currently, no hedge funds are holding shares in IN:TTKHLTCARE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

TTK Healthcare Limited

TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, and food businesses in India and internationally. Its Animal Welfare segment deals in various therapeutic formulations and feed supplements for veterinary use. The company's Consumer Products segment is involved in the marketing and distribution of Woodward's Gripewater, EVA range of cosmetics, Good Home range of scrubbers, air fresheners, etc. its Medical Devices segment manufactures and distributes artificial heart valves; and develops orthopedic implants and instruments. The company's Protective Devices segment manufactures and markets male contraceptives and other allied products. Its Foods segment engages in the manufacturing and marketing of food products, including potato and cereal based pellets. The company's Others segment prints and publishes maps and atlases. Its Human Pharma segment deals in herbal and allopathic formulations for human use. The company was incorporated in 1958 and is headquartered in Chennai, India. TTK Healthcare Limited is a subsidiary of TT Krishnamachari & Co., Ltd.